Teviah Sachs, MD
Surgical Oncology · Boston, MANPI 1821238205
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (43.1%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 5 manufacturers reported payments, led by Davol Inc. at 43.1% of the total.
Across 9 payments — averaging $515.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Davol Inc.$2K
- BK Medical Holding Company Inc.$1K
- Intuitive Surgical$957
- Smith+Nephew$149
- Johnson & Johnson$134
Across 6 payments — averaging $13,984 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genentech, Inc.$84K
What the payments were for
- Consulting fees$1,40030%
- Speaking & faculty fees$2,00043%
- Travel & lodging$95721%
- Food & beverage$2836%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Davol Inc. | 1 | $2,000 |
| BK Medical Holding Company Inc. | 1 | $1,400 |
| Intuitive Surgical | 4 | $957 |
| Smith+Nephew | 2 | $149 |
| Johnson & Johnson | 1 | $134 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,640 in reported general payments places this provider in the 75th percentile of 55 surgical oncology providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other surgical oncology in Boston
- Thanh BarbieBoston$108K
- Elizabeth MittendorfBoston$73K
- Genevieve BolandBoston$53K
- Eduardo Vega PizarroBoston$46K
- Monica Valero CamachoBoston$30K
- Jiping WangBoston$14K
- Arthur MoserBoston$12K
- Katherina CalvilloBoston$5K
- Motaz QadanBoston$4K
- Nicole Look-HongBoston$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.